NASDAQ:AVCO
Delisted

Avalon Globocare Stock News

etoro logo Buy AVCO
*Your capital is at risk
$3.34
+0 (+0%)
At Close: Apr 10, 2023
FREEHOLD, N.J., Oct. 21, 2019 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced plans to.
FREEHOLD, N.J., Sept. 19, 2019 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced it has.
Avalon GloboCare Corp. (AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, today announced it has secured a $20 million credit facility provided by the Compa
FREEHOLD, N.J., July 22, 2019 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, today announced.
FREEHOLD, N.J., July 22, 2019 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, today announced.
CD19 CAR-T candidate, AVA-001, has entered first-in-human clinical study for relapsed/refractory B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma in July.

18 Stocks Joining The Russell Indices

06:19pm, Friday, 28'th Jun 2019
The Russell 2000 Index is a small-cap stock market index that includes the bottom 2,000 companies found in the Russell 3000 index. The Russell Microcap Index includes the 1,000 smallest securities fou
FREEHOLD, N.J., June 26, 2019 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company.
Low-priced biotech stocks are often targets of pump-and-dump manipulation scams or other activity designed to make money for a select few, not you (think
ITMC-2019 Conference Valencia, Spain
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE